Literature DB >> 8200561

Pouchitis: result of microbial imbalance?

J G Ruseler-van Embden1, W R Schouten, L M van Lieshout.   

Abstract

To elucidate the role of microbiological factors in pouchitis, this study investigated the composition of ileal reservoir microflora, the mucus degrading capacity of bacterial enzymes as well as the pH and the proteolytic activity of pouch effluent. Stool samples were collected from five patients with pouchitis and nine patients without pouchitis. The flora of patients with pouchitis had an increased number of aerobes, a decreased ratio anaerobes to aerobes, less bifidobacteria and anaerobic lactobacilli, more Clostridium perfringens, and several species that were not found in control patients (for example, fungi). Furthermore the pH was significantly higher in patients with pouchitis (median value 6.5) than in control patients (5.4). To find out if the pH might influence the breakdown of intestinal mucus glycoproteins, the activity of glycosidases and proteases, and the degradation of hog gastric mucin by the pouch flora was tested at pH 5.2-7.6. Some glycosidases were inhibited, others were stimulated by a low pH, however, in each sample the proteolytic activity was inhibited for 75% at pH 5.2 compared with pH 6.8 and 7.6. Degradation of hog gastric mucin by the pouch flora was an active process at pH 7.2: within two to four hours of incubation more than half of the mucin was degraded. At pH 5.2 it took twice as long. It is concluded that pouchitis possibly results from instability of the flora in the pouch, which causes homeostasis to disappear (dysbiosis), and the protection of the pouch epithelium by the mucus layer becomes affected by increased activity of bacterial and host derived enzymes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200561      PMCID: PMC1374752          DOI: 10.1136/gut.35.5.658

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  54 in total

Review 1.  Ileal pouch-anal anastomosis: state of the art.

Authors:  J P Pena; B T Gemlo; D A Rothenberger
Journal:  Baillieres Clin Gastroenterol       Date:  1992-03

2.  Changes in bacterial composition and enzymatic activity in ileostomy and ileal reservoir during intermittent occlusion: a study using dogs.

Authors:  J G Ruseler-van Embden; W R Schouten; L M van Lieshout; H J Auwerda
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

Review 3.  The control and consequences of bacterial fermentation in the human colon.

Authors:  J H Cummings; G T Macfarlane
Journal:  J Appl Bacteriol       Date:  1991-06

4.  Control of muscle tone in the human colon.

Authors:  C J Steadman; S F Phillips; M Camilleri; N J Talley; A Haddad; R Hanson
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

5.  Studies of intestinal microflora. IV. The microflora of ileostomy effluent: a unique microbial ecology.

Authors:  S L Gorbach; L Nahas; L Weinstein; R Levitan; J F Patterson
Journal:  Gastroenterology       Date:  1967-12       Impact factor: 22.682

6.  Role of oxygen free radicals in the etiology of pouchitis.

Authors:  K E Levin; J H Pemberton; S F Phillips; A R Zinsmeister; M E Pezim
Journal:  Dis Colon Rectum       Date:  1992-05       Impact factor: 4.585

7.  Comparison of fermentation reactions in different regions of the human colon.

Authors:  G T Macfarlane; G R Gibson; J H Cummings
Journal:  J Appl Bacteriol       Date:  1992-01

8.  Microbiologic assessment of tissue biopsy samples from ileal pouch patients.

Authors:  A B Onderdonk; A M Dvorak; R L Cisneros; R S McLeod; D Antionoli; W Silen; J E Blair; R A Monahan-Earley; J Cullen; Z Cohen
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Familial adenomatous polyposis: results following ileal pouch-anal anastomosis and ileorectostomy.

Authors:  W L Ambroze; R R Dozois; J H Pemberton; R W Beart; D M Ilstrup
Journal:  Dis Colon Rectum       Date:  1992-01       Impact factor: 4.585

10.  Superior results of ileoanal pull through (IAPT) in polyposis coli vs ulcerative colitis patients.

Authors:  M T Dayton; W E Faught; J M Becker; R Burt
Journal:  J Surg Res       Date:  1992-02       Impact factor: 2.192

View more
  43 in total

1.  Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.

Authors:  T Kühbacher; P Gionchetti; J Hampe; U Helwig; P Rosenstiel; M Campieri; H J Buhr; S Schreiber
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  Probiotics and inflammatory bowel disease.

Authors:  Daisy Jonkers; Reinhold Stockbrügger
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

3.  The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease.

Authors:  Marleen H M C van Nuenen; Koen Venema; Janneke C J van der Woude; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

4.  The bacterial pathogenesis and treatment of pouchitis.

Authors:  S D McLaughlin; S K Clark; P P Tekkis; R J Nicholls; P J Ciclitira
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 5.  Probiotics in the management of inflammatory bowel disease.

Authors:  Robert M Penner; Richard N Fedorak
Journal:  MedGenMed       Date:  2005-07-18

6.  Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients.

Authors:  Gundi Heuschen; Christine Leowardi; Ulf Hinz; Frank Autschbach; Andreas Stallmach; Christian Herfarth; Udo A Heuschen
Journal:  Int J Colorectal Dis       Date:  2006-06-13       Impact factor: 2.571

Review 7.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 8.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

9.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.

Authors:  T Mimura; F Rizzello; U Helwig; G Poggioli; S Schreiber; I C Talbot; R J Nicholls; P Gionchetti; M Campieri; M A Kamm
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.